These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32209584)

  • 1. Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study.
    Alexiadou K; Cuenco J; Howard J; Wewer Albrechtsen NJ; Ilesanmi I; Kamocka A; Tharakan G; Behary P; Bech PR; Ahmed AR; Purkayastha S; Wheller R; Fleuret M; Holst JJ; Bloom SR; Khoo B; Tan TM
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32209584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting levels of glicentin are higher in Roux-en-Y gastric bypass patients exhibiting postprandial hypoglycemia during a meal test.
    Poitou C; Bouaziz-Amar E; Genser L; Oppert JM; Lacorte JM; Le Beyec J
    Surg Obes Relat Dis; 2018 Jul; 14(7):929-935. PubMed ID: 29703503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.
    Roberts GP; Kay RG; Howard J; Hardwick RH; Reimann F; Gribble FM
    Surg Obes Relat Dis; 2018 May; 14(5):562-568. PubMed ID: 29548882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity.
    Perakakis N; Kokkinos A; Angelidi AM; Tsilingiris D; Gavrieli A; Yannakoulia M; Tentolouris N; Mantzoros CS
    Clin Nutr; 2022 Sep; 41(9):1969-1976. PubMed ID: 35961260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals.
    Stefanakis K; Kokkinos A; Simati S; Argyrakopoulou G; Konstantinidou SK; Kouvari M; Kumar A; Kalra B; Mantzoros CS
    Clin Nutr; 2023 Aug; 42(8):1369-1378. PubMed ID: 37418844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial.
    Perakakis N; Kalra B; Angelidi AM; Kumar A; Gavrieli A; Yannakoulia M; Mantzoros CS
    Metabolism; 2022 Apr; 129():155157. PubMed ID: 35114286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials.
    Perakakis N; Kokkinos A; Peradze N; Tentolouris N; Ghaly W; Pilitsi E; Upadhyay J; Alexandrou A; Mantzoros CS
    Metabolism; 2019 Dec; 101():153997. PubMed ID: 31672446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
    Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
    Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
    Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T
    Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial plasma GLP-1 levels are elevated in individuals with postprandial hypoglycaemia following Roux-en-Y gastric bypass - a systematic review.
    Jalleh RJ; Umapathysivam MM; Plummer MP; Deane A; Jones KL; Horowitz M
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1075-1088. PubMed ID: 37439960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss.
    Nielsen MS; Ritz C; Wewer Albrechtsen NJ; Holst JJ; le Roux CW; Sjödin A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32016415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
    Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
    Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
    Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ
    Surg Obes Relat Dis; 2007; 3(6):597-601. PubMed ID: 17936091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
    Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
    Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On measurements of glucagon secretion in healthy, obese, and Roux-en-Y gastric bypass operated individuals using sandwich ELISA.
    Wewer Albrechtsen NJ; Kjeldsen SAS; Jensen NJ; Rungby J; Veedfald S; Bojsen-Møller KN; Dirksen C; Jensen CZ; Martinussen C; Madsbad S; Holst JJ
    Scand J Clin Lab Invest; 2022 Feb; 82(1):75-83. PubMed ID: 34935574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery.
    Jensen CZ; Bojsen-Møller KN; Svane MS; Holst LM; Hermansen K; Hartmann B; Wewer Albrechtsen NJ; Kuhre RE; Kristiansen VB; Rehfeld JF; Clausen TR; Holst JJ; Madsbad S
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G661-G672. PubMed ID: 32068442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.